Outcomes of a Deep Inferior Epigastric Perforator Flap Program


The purpose of this study is to analyze an institution's experience with starting a subspecialized DIEP flap program and to determine whether other hospitals would benefit from instituting a similar program. Prior studies have compared the outcome from a DIEP flap program with that of TRAM flaps within the same center. Other studies have calculated the cost of a DIEP flap and its complication rate. However, no one has examined the overall effects of a subspecialized reconstruction program and its impact on a health center. In this study, we will determine if the institutionalization of a DIEP flap program has increased our center's rate of breast reconstruction, as well as evaluate its outcomes and overall financial viability.

Study Start Date

September 2007

Estimated Completion Date

September 2017


No interventions cited


  • Oncology: Breast
  • Physician Assistant: Hematology/Oncology,Obstetrics/Gynecology

MeSH Terms

  • Breast Cancer
  • Breast Neoplasms

Study ID

Beth Israel Deaconess Medical Center -- 2007-P-000232/1



Trial ID


Study Type


Trial Phase


Enrollment Quota



Beth Israel Deaconess Medical Center

Inclusion Criteria

  • Intraductal carcinoma
  • Lobular carcinoma
  • Infiltrating ductal carcinoma
  • Paget's disease
  • BRCA positive

Exclusion Criteria

  • Inflammatory carcinoma of the breast




20 Years to 70 Years

Accepts Healthy Volunteers


Study Locations and Contact Information (2)

Study Location Distance Name Phone Email
Beth Israel Deaconess Medical Center - Boston, Massachusetts 2.4 miles None None None
Beth Israel Deaconess Medical Center - Boston, Massachusetts 2.4 miles Bernard T Lee MD 617-632-7835 blee3@bidmc.harvard.edu

ClinicalTrialsLocator.com provides clinical trial listings in an easy to view format. All clinical trial information is pulled directly from ClinicalTrials.gov. This website does not guarantee acceptance into any clinical trial, and is not responsible for adverse events that may be incurred from a clinical trial.